Gene · 28402
Papers3,091
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,091
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lights and shades of front-line treatment with covalent BTK inhibitors combined with venetoclax in patients with chronic lymphocytic leukemia. | Oncol Rev | 2025 | 41488721 | PubTator, text mining | PubMed |
| THE IGLV3-21 LIGHT CHAIN ANALYSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS. | Probl Radiac Med Radiobiol | 2025 | 41469354 | PubTator, text mining | PubMed |
| [Efficacy and long-term follow-up report of FCR regimen in the first-line treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma]. | Zhonghua Xue Ye Xue Za Zhi | 2025 | 41407461 | PubTator, text mining | PubMed |
| Comment on "Methylation-based droplet digital polymerase chain reaction shows high concordance with chronic lymphocytic leukemia IGHV somatic mutation status". | Am J Clin Pathol | 2025 | 41348948 | PubTator, text mining | PubMed |
| Chronic viral infections impaired the growth process of splenic B cells by upregulating Bbc3 and Atf3 in LCMV-CL13 infected mouse model. | Virulence | 2025 | 41329555 | PubTator, text mining | PubMed |
| Associations between genetic variations of HLA and IGHV, vaccination schedule, and COVID-19 vaccine immunogenicity. | NPJ Vaccines | 2025 | 41249154 | PubTator, text mining | PubMed |
| ctDNA MRD after CAR-T. | Blood Adv | 2025 | 41171267 | PubTator, text mining | PubMed |
| From Chronic Lymphocytic Leukemia to Plasmablastic Myeloma: Beyond the Usual Richter Transformation. | Curr Oncol | 2025 | 41149470 | PubTator, text mining | PubMed |
| Lymphoplasmacytic lymphoma with IgG-λ and free λ light chain paraprotein: A case report. | Medicine (Baltimore) | 2025 | 41088623 | PubTator, text mining | PubMed |
| [First-line treatment of elderly patients with CLL: An innovative, chemo-free approach]. | Dtsch Med Wochenschr | 2025 | 41072429 | PubTator, text mining | PubMed |
| Landscape of TP53 abnormalities and IGHV mutational profile in untreated Australian patients with chronic lymphocytic leukaemia. | Pathology | 2025 | 41068045 | PubTator, text mining | PubMed |
| Mutation profiling in differential diagnosis between TdT-positive high-grade/large B-cell lymphoma and B-lymphoblastic leukaemia/lymphoma. | J Pathol | 2025 | 41047873 | PubTator, text mining | PubMed |
| NOTCH1 Mutation Is Associated With Response to Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: A Retrospective Study. | EJHaem | 2025 | 41018006 | PubTator, text mining | PubMed |
| Prediction models for different types of leukemia: a systematic review and critical appraisal. | J Cancer Res Clin Oncol | 2025 | 41014388 | PubTator, text mining | PubMed |
| Re-emergence of circulating non-malignant B cells as a prognostic biomarker in chronic lymphocytic leukaemia. | Sci Rep | 2025 | 41006384 | PubTator, text mining | PubMed |
| Continuous DNA Methylation Deconvolution-Based Surrogate for B-Cell Differentiation State in CLL. | bioRxiv | 2025 | 41000815 | PubTator, text mining | PubMed |
| TAG-CLL, a Novel Tagmentation-Based Approach to Somatic Hypermutation Testing of IGHV Reveals the Weak Points of Both Sanger and Next-Generation Sequencing Methods. | J Mol Diagn | 2025 | 40998002 | PubTator, text mining | PubMed |
| Chronic lymphocytic leukemia: criteria for first-line therapeutic choice-an opinion paper. | Med Oncol | 2025 | 40996474 | PubTator, text mining | PubMed |
| Friends in need: The value of supportive colleagues in research. | Hemasphere | 2025 | 40989018 | PubTator, text mining | PubMed |
| Navigating the Landscape of Exosomal microRNAs: Charting Their Pivotal Role as Biomarkers in Hematological Malignancies. | Noncoding RNA | 2025 | 40981381 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28402/papers?page=5